Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RxSpan MD vs TrueMe

By GLP-1 ScorecardUpdated

RxSpan MD
Site position #4

Higher score

TrueMeFactor scores not reassessed.
Site position #176

Lower score

Score comparison

RxSpan MD has the higher recorded score — 84.3/100 to 67.6/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Before you choose

RxSpan MD does not publish a semaglutide price, so its RxSpan MD review sets out what it does disclose, while the TrueMe review explains the conditions attached to TrueMe's figure. The semaglutide cost page compares published rates across the field. Ask RxSpan MD for a written total before treating either one as the cheaper choice.

If neither one fits, RxSpan MD vs Unique Physique and TrueMe vs Tuyo Health compare each of them with another graded program, and the list of alternatives to RxSpan MD ranks the programs closest to RxSpan MD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRxSpan MD +24
86
62
Dose & formulationRxSpan MD +12
89
77
Clinical oversightRxSpan MD +10
88
78
Labs & monitoringRxSpan MD +31
83
52
FulfillmentRxSpan MD +8
89
81
Contract termsRxSpan MD +8
53
45
RxSpan MD · top barTrueMe · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricRxSpan MDTrueMe
WeighScore84.3/10067.6/100
GradeBC
Site position#4#176
SemaglutideCurrent compounded quote unconfirmedCompounded "GLP-1" (drug not named) $139 for one month, $89 a month on a 3-month plan
TirzepatideCurrent compounded quote unconfirmedCompounded "GLP-1/GIP" (drug not named) $149 for one month, $99 a month on a 3-month plan
CoverageConfirm treatment availability during intake6 states
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
RxSpan MD

Site position #4 · B

Strengths

  • Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
  • Public terms describe independent healthcare providers
  • Homepage describes messaging and care-team appointments

What to consider

  • Homepage advertises compounded plans that the current catalog did not substantiate
  • Current oral GLP-1 availability is unconfirmed
  • Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
  • Public terms do not establish unused prepaid-treatment refund amounts
TrueMe

Site position #176 · C

Factor scores not reassessed.

Strengths

  • One price covers consultation, medication, shipping, supplies and provider support, and the site states there are no separate membership fees
  • Same price at every dose, so the cost does not climb as a provider titrates the dose upward
  • Full pricing is published up front — no intake form is required before you can see what you will pay
  • Names its telehealth platform (Telegra) and physician network (Strive), and the returns address names CarePoint Infusion Pharmacy in Stafford, Texas

What to consider

  • Serves only six states (AZ, CO, MO, PA, TX, WI), far narrower coverage than most national GLP-1 telehealth
  • Prices marketed per month are charged every 4 weeks at checkout — 13 charges a year, not 12
  • You pay before completing the medical intake, and approval is not guaranteed at the moment you are charged
  • The 3-month rates ($119 and $139/mo) are a single upfront charge of $357 or $417, not a lower monthly plan
  • A Featured In strip shows CNN, Fox News, Forbes, New York Times and NPR logos with no linked coverage

Featured provider

RxSpan MD

RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard